Clinical impact of antibiotic-resistant Gram-positive pathogens
- 1 March 2009
- journal article
- review article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 15 (3), 212-217
- https://doi.org/10.1111/j.1469-0691.2009.02738.x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- All EU hands to the EU pumps: the Science Academies of Europe (EASAC) recommend strong support of research to tackle antibacterial resistanceClinical Microbiology & Infection, 2008
- A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐ResistantStaphylococcus aureusDisease in San Francisco, 2004–2005Clinical Infectious Diseases, 2008
- New strategies for combating multidrug-resistant bacteriaTrends in Molecular Medicine, 2007
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2007
- Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threatThe Lancet, 2006
- An International Prospective Study of Pneumococcal Bacteremia: Correlation with In Vitro Resistance, Antibiotics Administered, and Clinical OutcomeClinical Infectious Diseases, 2003
- Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysisClinical Infectious Diseases, 2003
- Emergence of Macrolide Resistance during Treatment of Pneumococcal PneumoniaNew England Journal of Medicine, 2002
- Molecular Epidemiology ofStreptococcus pneumoniaeCausing Invasive Disease in 5 CountriesThe Journal of Infectious Diseases, 2000